VCBeat Innovation Institute Completed! KEDOUBC Collaborates with Industry, Academia, Research, and Medicine to Unlock the Industrialization Code of Brain-Computer Interfaces

In 2025, China's brain-computer interface reaches a critical turning point from cutting-edge research to industrial implementation, demonstrating the limitless possibilities of hard technology empowering healthy living.

When we extend the time dimension and look back at the past decade of China's brain-computer interface industry, it is not difficult to find — this decade has been a field full of expectations and bubbles, visions and risks. On the one hand, cutting-edge technology has sparked endless imagination among capital and the public, with various domestic and foreign enterprises and investors rushing in. On the other hand, how to achieve sustainable development in the early stages when the technology is still imperfect and market demand has yet to explode remains a major challenge to this day.

Among a group of brain-computer interface companies launching an assault on the high ground of value,Kedou(Suzhou)Brain-Computer Technology Co., Ltd. (hereinafter referred to as "KEDOUBC"), established in 2016, delivered a distinctive report card in 2025.This innovative enterprise, which has deeply cultivated the entire industrial chain of electrophysiological hardware and focuses on the treatment of nerve-related diseases, has not only built up the full industrial chain development capability of "electrode R&D - equipment manufacturing - data algorithms - animal experiments - clinical transformation",Without financing, the company has achieved continuous profitability in the past three years.。

Based on the dual growth of technology and commerce, recently, KEDOUBC has formally joined hands with top expert teams from home and abroad to establish"Kedou Innovation Research Institute"——Further strengthen the integration of engineering technology capabilities,打通 brain-computer interface industry key chain links. For areas with basic technical theory support, strong market demand, but no related products available, focus on rapidly developing engineering prototypes from 0 to 1 based on existing engineering capabilities. Provide mature and reliable technical prototypes for subsequent industrial transformation in the brain-computer interface sector.

KEDOUBC CEO Quanwei Yang (left) and Professor Xueguo Zhang (right)

KEDOUBC Innovation Research Institute Inaugural Conference

Unlike some companies that chase policy trends and industry hype, KEDOUBC was not born during the "peak period" of brain-computer interfaces, but rather originated from a group of scientists' foresight into market demand and industry development.

KEDOUBC is developed by a team with over thirty years of experience in neuroscience research and electrode development.Professor Xueguo ZhangGuided by the initiative. However, in the first few years of its establishment, due to the immature market, the team's early attempts did not yield the desired commercial returns.KEDOUBC CEO Yang QuanweiAdmitted: "At that time, we only knew that we wanted to do something related to brain-computer interfaces, but we didn’t accurately determine what exactly it should be or what needs it should meet. However, since I come from a technical background, we firmly believe in first creating a product that is valuable and useful, and the market rewards will naturally follow."

This pragmatism has also become the fundamental logic for KEDOUBC's subsequent development. Around 2019, Yang Quanwei led the KEDOUBC team to enter the market through neural microelectrodes, which address the most basic and core frontline market demands.

Electrodes are the key front-end sensors in brain-computer interface systems for capturing neural signals and achieving neuromodulation. However, different application scenarios (such as cortical recording, deep brain stimulation, peripheral nerve modulation, etc.) impose vastly different requirements on the materials, forms, and manufacturing processes of electrodes. Due to these highly customized demands and technical requirements, the field of neuroscience in China has long faced challenges such as a lack of electrode variety, reliance on imports, and high costs.

Faced with this dilemma, KEDOUBC chose to drive R&D in reverse based on market demand. "In the early days, there were no brain-computer interface companies to refer to. We were completely guided by the scientific research market—customers presented their needs, and we worked to fulfill them. In the process, we continuously optimized performance and expanded product categories, gradually forming standardization from initial customization," said Yang Quanwei.

It is precisely based on this "customization-standardization" progressive path that KEDOUBC has gradually built one of the richest electrode product lines in China.

As of now, the company has independently developedMore than 40 types of electrodes, most of which are domestically首创 in China., including floating micro-needle array electrodes dedicated to brain-computer interfaces, independently adjustable micro-needle array electrodes, Needle-array electrodes for intraoperative positioning, Cuff electrodes for peripheral nerve stimulation and recording, and electrocorticography (ECoG) electrodes in various forms, covering more than 95% of the electrode product needs for brain-computer interfaces.

KEDOUBC Electrode Product Matrix

Since 2019, KEDOUBC has taken a path distinctly different from the industry's common "cash-burning" model – not only have all brain-computer interface products been sold, but some have also seen continuous bulk purchases from customers, with both the products and their value gaining widespread recognition.Currently, over 150 high-level papers have been published using KEDOUBC products, and the number is growing rapidly. The products have entered more than 1,000 universities, hospitals, and research institutions at home and abroad, capturing over 80% of China's research electrode market.

Annual Publication Statistics on KEDOUBC Products and Services Support

KEDOUBC Products and Services SupportYearStatistics on the Number of Journal Partitions Released by CAS

More importantly, KEDOUBC's products and services not only reduce research costs but, in a sense, expand the possibilities for neuroscience research in China. "Previously, many labs in China had limited funding or lacked suitable electrodes, so a Ph.D. student might have spent half their time manually crafting electrodes, which is a significant waste of resources. When we lower costs and diversify the types of electrodes available, researchers can focus their energy on truly scientifically valuable exploration," said Yang Quanwei.

The brain-computer interface industry is a comprehensive industry that integrates advanced technology, complex system integration, and diversified application scenarios. Based on the grand narrative of the current industry, if it only stayed at electrodes, the growth story of KEDOUBC might not be sufficiently leading.

In the interview, Yang Quanwei repeatedly mentioned a point of view: brain-computer interface is essentially an "electrophysiological technology", which will derive different market demands in different application scenarios and different development stages. Therefore, KEDOUBC's layout does not deliberately pursue "large and complete", but is a naturally extended ability closed-loop formed in the process of serving different customers——Guan"Electrode R&D, Equipment Support, Animal Experimentation, Clinical Transformation" full-industry-chain service capabilities.

On the one hand, the company has established a unique micro-nano processing technology in China, mastered core processes such as microelectrode wire straightening, tip forming, and exposure, which enable high-quality recording of single-neuron signals, and independently developed supporting electrode auxiliary equipment, forming a full-process technical system from material processing to precision manufacturing.

On the other hand, high-performance electrodes are only one part of the equation; the backend signal acquisition, processing, and stimulation equipment are equally critical. Based on this, KEDOUBC has simultaneously developed multiple electrophysiological recording and stimulation systems, forming a complete solution from hardware to services. Its business extends further into the medical device field (covering diagnosis and treatment of nerve-related diseases), breeding, sales, and services of large experimental animals, as well as terminal consumer products such as mechanical exoskeletons —A full-chain business layout covering scientific research, clinical, and consumer markets has been formed.

For example, the multi-channel and multi-mode integrated electrophysiological system KD-RHS-128A developed by KEDOUBC has the advantage of high integration, with nine functions including animal electrophysiological acquisition, electrical stimulation, non-invasive EEG cap acquisition, brain organoid recording, ex vivo brain slice recording, optogenetics, and real-time sleep analysis. It effectively reduces equipment investment for research institutions, making scientific research more efficient and economical.

In 2025, KEDOUBC successfully bridged the "last mile" of brain-computer interface technology implementation by obtaining its first Class II medical device registration certificate for a neuroelectric stimulation device used for pain relief.

Yang Quanwei stated, "The first clinical product may not necessarily become a ‘blockbuster,’ but its more significant meaning lies in helping the company establish a complete R&D, production, quality management, and registration system for medical devices, paving the way for the transformation of more innovative medical devices in the future. Now, our second product has already entered clinical trials, and the progress will be much faster."

Looking back on the company's decade-long journey, the establishment of the "Kedou Innovation Research Institute" marks another significant strategic upgrade for KEDOUBC.

From relying on KEDOUBC's engineering strength to transform early scientific discoveries into stable products, to verifying clinical treatment needs through KEDOUBC’s hardware and services, and further leveraging the KEDOUBC platform to connect with industry chain partners for demand alignment and technology transfer — over a decade of dedication, KEDOUBC has seamlessly integrated the interconnected development threads of technology and demand within the brain-computer interface market.

Speaking about the important strategy behind the establishment of the Research Institute, Yang Quanwei pointed out, "Most of our previous R&D work essentially aligns with what the Innovation Research Institute has been doing. The establishment of this Research Institute officially declares the company's future development direction—shifting from a past focus on short-term market returns to a model emphasizing mid-to-long-term technology strategies and cutting-edge exploration. It also sets a higher standard for the team, encouraging them to pursue more idealistic goals with greater longevity and determination."

These goals clearly point to three directions——Research Products and Large Animal Experiment Services, Medical Devices and Consumer Healthcare。

First, empower research and industry to promote ecological prosperity.Kedo Innovation Research Institute, as an open platform, will gather more researchers, clinical experts, and industry partners to jointly tackle technical bottlenecks and accelerate the transformation of results. Based on this, a large amount of user feedback will also provide the team with more objective and real data support, offering scientific guidance for future product development in more directions. Yang Quanwei stated: "We hope that through the research institute, we can drive more people to move forward together and promote the healthy development of the entire industry."

Secondly, focus on clinical medical devices to address essential needs."New technologies, while still imperfect, must address critical clinical needs in order to gain market acceptance." Therefore, KEDOUBC will focus on developing implantable or non-invasive neuromodulation devices for the treatment of hemiplegia, pain, depression, epilepsy, and other conditions. Among these, the clinical translation of invasive brain-computer interface products is at the core of the company’s product strategy. The company plans to leverage capital resources to jointly overcome this challenging area.

Finally, consumer-grade brain-computer interface products have a broader market space worth hundreds of billions.In Yang Quanwei's view, all technologies are good, but the key lies in making different arrangements at different times. Although there is still a considerable gap between the public's current understanding of brain-computer interfaces and the actual form of the products, he believes that the ultimate form of brain-computer interfaces may become an everyday tool for ordinary people to improve their quality of life and expand their capability boundaries, much like today’s smartphones.

KEDOUBC Selected by CCTV as a "Sample Enterprise in the Brain-Computer Interface Track"

Ten years to sharpen a sword, KEDOUBC provides a reference-worthy sample for China’s brain-computer interface industry, which is in the early stages of the Hype Cycle—industrializing cutting-edge technology requires both the idealism to aim for the stars and the diligence to cultivate the earth beneath our feet.

At the end of the interview, Yang Quanwei said, "We are a group of people who do things earnestly and hope to devote ourselves to...Interesting, Meaningful, ValuableThe career - 'Interesting' is the passion that keeps the team motivated, 'Meaningful' is the positive value for society, country, and individuals, and 'Valuable' is the economic support that generates market returns. These three aspects enable us to persist in the rapidly growing future industry of brain-computer interface over the long term."